Overview
News
Salaries
Products
People
Growth
Offices
Financials

Overview

Find more information about IMLYGIC® (talimogene laherparepvec), including how it works, savings information, and more. See Important Safety Info.

News

Press release PRNewswire 9 years ago
Amgen Presents New Phase 2 Data On IMLYGIC (Talimogene Laherparepvec) Investigational Combination At ASCO 2017
/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new data from the Phase 2
Read more
Report
News pi.amgen.com
Prescribing Information
If you would like more information, talk with your doctor.
Read more
Report
News pi.amgen.com
Medication Guide
If you would like more information, talk with your doctor.
Read more
Report